Literature DB >> 9770352

Phosphorylation of retinoblastoma protein assayed in individual HL-60 cells during their proliferation and differentiation.

G Juan1, X Li, Z Darzynkiewicz.   

Abstract

Expression of pRb and its state of phosphorylation were immunocytochemically assayed in individual HL-60 cells during their proliferation and after induction of differentiation, using mAb which detects hypophosphorylated pRb (pRbP-) combined with mAb which reacts with pRb regardless of its phosphorylation (total pRb; pRbT). Correlated measurements of pRbP-, pRbT, a ratio of pRbP-/pRbT, and cellular DNA content by flow cytometry revealed expression of total pRb and its phosphorylation state vis-à-vis the cell cycle position. Following mitosis (during the exponential phase of cell growth) a mixture of hypo- and hyperphosphorylated pRb was present within the cell for less than 2 h, i.e., early in G1; no hypophosphorylated pRb was detected throughout remainder of the cycle. Cellular pRb content was increasing primarily during G1 and the cell entrance to S was correlated with attainment of a distinct threshold level of pRb. No correlation was seen between the content of pRb per cell and its state of phosphorylation during G1. Cell differentiation whether induced by 1,25-dihydroxyvitamin D3, retinoic acid, or phorbol myristate acetate led to cell arrest primarily in G0/1. The G0/1 cells in these cultures, compared to G1 cells from the untreated cultures, had increased level of both pRbT and pRbP-. However, because the relative increase of pRbP- was disproportionally greater than of pRbT, the pRbP-/pRbT ratio of the differentiating cells was markedly elevated. The cells that still were in S and G2/M in the differentiating cultures also showed the presence of hypophosphorylated pRb. Our data suggest that the mechanism of irreversible cell cycle arrest during terminal differentiation involves both the increase in content of pRb and dephosphorylation of pRb already present within the cell. This provides a large pool of hypophosphorylated pRb that can effectively remove all free E2F, thereby precluding activation of the genes whose transcription is needed to pass the G1 restriction point. In contrast to terminal differentiation the transient quiescence (G0 state) manifests only by dephosphorylation of pRb, without a change in its cellular level. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770352     DOI: 10.1006/excr.1998.4165

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Elevated cyclin E levels, inactive retinoblastoma protein, and suppression of the p27(KIP1) inhibitor characterize early development of promyeloid cells into macrophages.

Authors:  Q Liu; R W VanHoy; J H Zhou; R Dantzer; G G Freund; K W Kelley
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 2.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

3.  Cytometry of chromatin bound Mcm6 and PCNA identifies two states in G1 that are separated functionally by the G1 restriction point.

Authors:  Phyllis S Frisa; James W Jacobberger
Journal:  BMC Cell Biol       Date:  2010-04-16       Impact factor: 4.241

Review 4.  The role of cell differentiation in controlling cell multiplication and cancer.

Authors:  Karl-Hartmut von Wangenheim; Hans-Peter Peterson
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-15       Impact factor: 4.553

Review 5.  Role of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells.

Authors:  X T Hu; K S Zuckerman
Journal:  Cell Prolif       Date:  2014-03-19       Impact factor: 6.831

6.  Single-cell analysis of CD4+ T-cell differentiation reveals three major cell states and progressive acceleration of proliferation.

Authors:  Valentina Proserpio; Andrea Piccolo; Liora Haim-Vilmovsky; Gozde Kar; Tapio Lönnberg; Valentine Svensson; Jhuma Pramanik; Kedar Nath Natarajan; Weichao Zhai; Xiuwei Zhang; Giacomo Donati; Melis Kayikci; Jurij Kotar; Andrew N J McKenzie; Ruddy Montandon; Oliver Billker; Steven Woodhouse; Pietro Cicuta; Mario Nicodemi; Sarah A Teichmann
Journal:  Genome Biol       Date:  2016-05-12       Impact factor: 13.583

7.  P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228.

Authors:  V Sandor; A Senderowicz; S Mertins; D Sackett; E Sausville; M V Blagosklonny; S E Bates
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.